NIH-funded research R21 grant

Improving HIV prevention through better delivery of PrEP in Kenya

Official title: Delivery of PrEP to Key Populations in Kenya: Applying Coincidence Analysis to Determine Effective Implementation Strategies

Funded at University of South Florida · NIH-10700586 · Data updated 2026-11-12

This study is looking at how to make it easier for people in Kenya who are at high risk of HIV to start and keep using a medication called PrEP to help prevent the virus, so they can stay healthy and safe.

More PrEP research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of South Florida
NIH-funded
Lab location1 site (Tampa, United States)
Project startSeptember 15, 2023
Project endSeptember 14, 2025
Funding year2023
Award (this year)$389,527
NIH project number1R21MH133508-01
Project IDNIH-10700586 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals in Kenya who are at high risk of acquiring HIV and are eligible for PrEP.

Less likely to help

Patients who are not at risk for HIV or those who do not reside in Kenya may not benefit from this research.

What this research studies

This research investigates how to enhance the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention among key populations in Kenya. It aims to identify effective implementation strategies and contextual factors that influence the initiation and persistence of PrEP use. By analyzing existing programs and collecting data from healthcare organizations, the study seeks to understand what works best in encouraging individuals at high risk of HIV to start and continue using PrEP. The findings will help improve HIV prevention efforts in the region.

Why it matters

Potential benefit: If successful, this research could lead to increased access to and sustained use of PrEP, significantly reducing the risk of HIV transmission among vulnerable populations.

How similar studies have gone: Previous research has shown success in improving PrEP uptake through targeted implementation strategies, making this approach both relevant and promising.

Where this research is happening

  • University of South Florida
    Tampa, United States
    Active

Researchers

  • Principal investigator: Turner, Deanne — University of South Florida
  • Study coordinator: Turner, Deanne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.